Abatacept Retention Rates, Overall and By Participating Country, and Prognostic Factors of Retention in Patients with RA: 2-Year Results from a Real-World Observational Study

被引：0
|
作者：
Alten, Rieke [1 ]
Lorenz, H. M. [2 ]
Mariette, X. [3 ]
Nuesslein, H. G. [4 ]
Galeazzi, M. [5 ]
Navarro, F. [6 ]
Chartier, M. [7 ]
Elbez, Y. [8 ]
Rauch, C. [9 ]
Le Bars, M. [7 ]
机构：
[1] Schlosspk Klin Univ Med, Berlin, Germany
[2] Univ Hosp, Heidelberg, Germany
[3] Univ Paris Sud, Paris, France
[4] Univ Erlangen Nurnberg, Nurnberg, Germany
[5] Univ Siena, Siena, Italy
[6] Hosp Univ Virgen Macarena, Seville, Spain
[7] Bristol Myers Squibb, Rueil Malmaison, France
[8] Excelya, Boulogne, France
[9] Bristol Myers Squibb, Munich, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1468
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Abatacept Retention Rates and Prognostic Factors of Retention in Patients with Rheumatoid Arthritis (RA) Treated in Canada: 2-Year Results from a Real-World Observational Study
    Haraoui, Boulos
    Choquette, Denis
    Bessette, Louis
    Khraishi, Majed
    Maoui, Meryem
    Heitzmann, Julia
    Connolly, Sean
    Alten, Rieke
    [J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 980 - 980
  • [2] ABATACEPT RETENTION RATES AND PROGNOSTIC FACTORS OF RETENTION IN PATIENTS WITH RHEUMATOID ARTHRITIS: 2-YEAR RESULTS FROM THE REAL-WORLD ACTION STUDY
    Alten, R.
    Lorenz, H-M.
    Mariette, X.
    Nuesslein, H.
    Galeazzi, M.
    Navarro, F.
    Chartier, M.
    Elbez, Y.
    Rauch, C.
    Le Bars, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 577 - 578
  • [3] Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study
    Rieke Alten
    Xavier Mariette
    René-Marc Flipo
    Roberto Caporali
    Maya H. Buch
    Yusuf Patel
    Sara Marsal
    Raimon Sanmartí
    Michael T. Nurmohamed
    Hedley Griffiths
    Peter Peichl
    Bettina Bannert
    Melanie Chartier
    Sean E. Connolly
    Karissa Lozenski
    Christiane Rauch
    [J]. Clinical Rheumatology, 2022, 41 : 2361 - 2373
  • [4] Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study
    Alten, Rieke
    Mariette, Xavier
    Flipo, Rene-Marc
    Caporali, Roberto
    Buch, Maya H.
    Patel, Yusuf
    Marsal, Sara
    Sanmarti, Raimon
    Nurmohamed, Michael T.
    Griffiths, Hedley
    Peichl, Peter
    Bannert, Bettina
    Chartier, Melanie
    Connolly, Sean E.
    Lozenski, Karissa
    Rauch, Christiane
    [J]. CLINICAL RHEUMATOLOGY, 2022, 41 (08) : 2361 - 2373
  • [5] Prognostic Factors for IV Abatacept Retention in Patients Who Have Received at Least One Prior Biologic Agent: 2-Year Results from a Prospective, International, Real-World Study
    Nuesslein, H.
    Alten, R.
    Galeazzi, M.
    Lorenz, H. M.
    Nurmohamed, M. T.
    Bensen, W. G.
    Burmester, Gerd
    Peter, H-H
    Peichl, P.
    Pavelka, K.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    Le Bars, M.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1087 - S1088
  • [6] PROGNOSTIC FACTORS FOR INTRAVENOUS ABATACEPT RETENTION IN PATIENTS WHO HAVE RECEIVED AT LEAST ONE PRIOR BIOLOGIC AGENT: 2-YEAR RESULTS FROM A PROSPECTIVE, INTERNATIONAL, REAL-WORLD STUDY
    Nuesslein, Hubert
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hanns-Martin
    Nurmohamed, Michael T.
    Bensen, William G.
    Burmester, Gerd R.
    Peter, Hans-Hartmut
    Peichl, Peter
    Pavelka, Karel
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. RHEUMATOLOGY, 2015, 54 : 77 - 78
  • [7] Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study
    Peichl, Peter
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hanns-Martin
    Nuesslein, Hubert
    Navarro, Federico
    Elbez, Yedid
    Chartier, Melanie
    Hackl, Roland
    Rauch, Christiane
    Connolly, Sean E.
    [J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 2020, 170 (5-6) : 132 - 140
  • [8] ANTI-CITRULLINATED PROTEIN ANTIBODY SEROSTATUS DETERMINES 2-YEAR RETENTION OF IV AND SC ABATACEPT IN PATIENTS WITH RA IN A REAL-WORLD SETTING
    Allen, R.
    Rauch, C.
    Chartier, M.
    Nurmohamed, M. T.
    Connolly, S.
    Buch, M. H.
    Peichl, P.
    Mariette, X.
    Patel, Y.
    Marsal, S.
    Caporali, R.
    Griffiths, H.
    Sanmarti, R.
    Bannert, B.
    Elbez, Y.
    Lozenski, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 511 - 512
  • [9] Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study
    Alten, Rieke
    Mariette, Xavier
    Lorenz, Hanns-Martin
    Nuesslein, Hubert
    Galeazzi, Mauro
    Navarro, Federico
    Chartier, Melanie
    Heitzmann, Julia
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. CLINICAL RHEUMATOLOGY, 2019, 38 (05) : 1413 - 1424
  • [10] Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study
    Rieke Alten
    Xavier Mariette
    Hanns-Martin Lorenz
    Hubert Nüßlein
    Mauro Galeazzi
    Federico Navarro
    Melanie Chartier
    Julia Heitzmann
    Coralie Poncet
    Christiane Rauch
    Manuela Le Bars
    [J]. Clinical Rheumatology, 2019, 38 : 1413 - 1424
12345